Inactive Instrument

Lucira Health, Inc.

LHDX

US54948U1051

Lucira Health, Inc. Provides Revenue Guidance for the Three Months Ended March 31, 2021

April 12, 2021 at 07:00 am EDT

Lucira Health, Inc. provided revenue guidance for the three months ended March 31, 2021. Lucira expects net revenue for the three months ended March 31, 2021 of approximately $4.0 million to $4.5 million.

Latest news about Lucira Health, Inc.

Lucira Health, Inc. Went Out of Business	23-10-04	CI
Anebulo Pharmaceuticals Appoints Daniel George as Part-Time Finance Chief	23-09-29	MT
Lucira Health, Inc. Announces Board and Executive Changes	23-09-25	CI
Lucira Health, Inc. Announces Erik T. Engelson, Chief Executive Officer Resigned from the Position	23-09-25	CI
Lucira Health, Inc. Announces Richard Narido, Chief Financial Officer Resigned from the Position	23-09-25	CI
First Amended Liquidation Plan Approved for Lucira Health, Inc.	23-09-19	CI
First Amended Liquidation Plan Filed by Lucira Health, Inc.	23-09-13	CI
Modified Disclosure Statement Approved on Interim Basis for Lucira Health, Inc.	23-07-28	CI
First Motion for Exclusivity Period Extension Approved For Lucira Health, Inc.	23-07-10	CI
First Motion for Exclusivity Period Extension Filed by Lucira Health, Inc.	23-06-22	CI
Liquidation Plan and Disclosure Statement Filed by Lucira Health, Inc.	23-06-07	CI
Pfizer Inc. acquired Substantially All of the Assets of Lucira Health, Inc.	23-04-19	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-19	CI
Aditxt's Pearsanta Unit Selected as Backup Bidder to Acquire Lucira Health's Assets	23-04-17	MT
Aditxt Says Unit Pearsanta Submitted Bid to Acquire All of Lucira Health Assets	23-04-17	CI
North American Morning Briefing : Stock Futures -3-	23-04-13	DJ
Asset Purchase Agreement Filed by Lucira Health, Inc.	23-04-12	CI
Pfizer Inc. entered in to an auction to acquire Substantially All of the Assets of Lucira Health, Inc. for $36.4 million.	23-04-09	CI
North American Morning Briefing : Further Caution -2-	23-04-06	DJ
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-05	CI
Bidding Procedure Approved for Lucira Health, Inc.	23-03-27	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-03-24	CI
Lucira Health, Inc.(OTCPK:LHDX.Q) dropped from NASDAQ Composite Index	23-03-03	CI
Motion for Asset Sale Filed by Lucira Health, Inc.	23-03-02	CI
Lucira Health, Inc.(NasdaqGS:LHDX) dropped from S&P TMI Index	23-02-28	CI

Chart Lucira Health, Inc.

Duration

Period

More charts

Company Profile

Lucira Health, Inc. is a United States-based company. The Company has no business operations and is in liquidation.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+107.49%	6.55B
APPLE ISPORTS GROUP, INC.	+98.02%	1.23B
CHURCHILL CAPITAL CORP VII	+2.38%	986M
PERELLA WEINBERG PARTNERS	+15.17%	752M
ARES ACQUISITION CORPORATION II	+2.01%	666M
E7 GROUP	+2.33%	620M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+7.78%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies